Late recurrence of non-small cell lung cancer more than 5 years after complete resection: Incidence and clinical implications in patient follow-up

Chest

Volumn 138, Issue 1, 2010, Pages 145-150

  Maeda, Ryo ^a   Yoshida, Junji ^a   Hishida, Tomoyuki ^a   Aokage, Keiju ^a   Nishimura, Mitsuyo ^a   Nishiwaki, Yutaka ^a   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FOLLOW UP; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; METASTASIS; PRIORITY JOURNAL;

EID: 77954699135     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-2361     Document Type: Article

References (14)

1. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg. 1995;109(1):120-129.
2. al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur J Cardiothorac Surg. 1997;12(3):380-384.
3. Martin J, Ginsberg RJ, Venkatraman ES, et al. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer. J Clin Oncol. 2002;20(8):1989-1995. (Pubitemid 34408788)
4. Okada M, Nishio W, Sakamoto T, Harada H, Uchino K, Tsubota N. Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma. J Thorac Cardiovasc Surg. 2003;126(2):558-562. (Pubitemid 37048526)
5. Martini N, Rusch VW, Bains MS, et al. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg. 1999;117(1):32-36.
6. Martini N, Melamed MR. Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975;70(4):606-612.
7. Travis WD, Brambilla E, Muller-Hermelink HK, et al. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press; 2004.
8. Sobin L, Wittekind C; IUA Cancer. TNM Classification of Malignant Tumors. 5th ed. New York, NY: Wiley-Liss; 1997.
9. Pairolero PC, Williams DE, Bergstralh EJ, Piehler JM, Bernatz PE, Payne WS. Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg. 1984;38(4):331-338.
10. Thomas PA Jr, Rubinstein L; The Lung Cancer Study Group. Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1993;106(6):1053-1058.
11. Pasini F, Pelosi G, Valduga F, et al. Late events and clinical prognostic factors in stage I non small cell lung cancer. Lung Cancer. 2002;37(2):171-177. (Pubitemid 34831809)
12. Sugimura H, Nichols FC, Yang P, et al. Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007;83(2):409-417.
13. Tsuboi M, Ohira T, Saji H, et al. The present status of post-operative adjuvant chemotherapy for completely resected non-small cell lung cancer. Ann Thorac Cardiovasc Surg. 2007;13(2):73-77.
14. Johnson BE, Rabin MS. Patient subsets benefiting from adjuvant therapy following surgical resection of nonsmall cell lung cancer. Clin Cancer Res. 2005;11(13):5022-5026.